Page last updated: 2024-11-02

oxidopamine and B16 Melanoma

oxidopamine has been researched along with B16 Melanoma in 2 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horvathova, L1
Padova, A1
Tillinger, A1
Osacka, J1
Bizik, J1
Mravec, B1
Basu, S1
Sarkar, C1
Chakroborty, D1
Nagy, J1
Mitra, RB1
Dasgupta, PS1
Mukhopadhyay, D1

Other Studies

2 other studies available for oxidopamine and B16 Melanoma

ArticleYear
Sympathectomy reduces tumor weight and affects expression of tumor-related genes in melanoma tissue in the mouse.
    Stress (Amsterdam, Netherlands), 2016, Volume: 19, Issue:5

    Topics: Animals; Apoptosis; Caspase 3; Gene Expression Regulation, Neoplastic; Male; Melanoma, Experimental;

2016
Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis.
    Cancer research, 2004, Aug-15, Volume: 64, Issue:16

    Topics: Animals; Cell Division; Denervation; Dopamine; Endothelium, Vascular; Male; Melanoma, Experimental;

2004